ONWARD Medical: BCI platform is awarded BDD by FDA
ONWARD reported this morning that its system ARC-BCI system has been awarded Breakthrough Device Designation (BDD) by the FDA. Such a decision has been backed by two feasibility studies where the Brain-Computer Interface has proven to be a cutting-edge AI technology enabling movement-related though
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.